14 VCs and 1 funds investing in Pharmaceuticals
Managing Partner
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Pietro Puglisi invests or supports investment decisions through Claris Ventures's published strategy: Build and invest in biopharma companies arising from the Italian research ecosystem around transformational therapies for major unmet patient needs.
Managing Partner
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Ciro Spedaliere invests or supports investment decisions through Claris Ventures's published strategy: Build and invest in biopharma companies arising from the Italian research ecosystem around transformational therapies for major unmet patient needs.
Partner
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Giulia Vestri invests or supports investment decisions through Claris Ventures's published strategy: Build and invest in biopharma companies arising from the Italian research ecosystem around transformational therapies for major unmet patient needs.
Investment Manager
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Paolo Vigo invests or supports investment decisions through Claris Ventures's published strategy: Build and invest in biopharma companies arising from the Italian research ecosystem around transformational therapies for major unmet patient needs.
Senior Associate
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Gianmarco Pallavicini invests or supports investment decisions through Claris Ventures's published strategy: Build and invest in biopharma companies arising from the Italian research ecosystem around transformational therapies for major unmet patient needs.
Associate
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Giuditta Magnifico invests or supports investment decisions through Claris Ventures's published strategy: Build and invest in biopharma companies arising from the Italian research ecosystem around transformational therapies for major unmet patient needs.
Finance and Administration Manager
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Raffaele Troya is listed in a Finance and Administration Manager capacity at Claris Ventures. The firm does not publish a person-specific investment thesis for this role; firm strategy is included only as shared context.
Internal Accounting and Administration
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Araceli Albano is listed in a Internal Accounting and Administration capacity at Claris Ventures. The firm does not publish a person-specific investment thesis for this role; firm strategy is included only as shared context.
Senior Advisor
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Roberto De Ponti is listed in a Senior Advisor capacity at Claris Ventures. The firm does not publish a person-specific investment thesis for this role; firm strategy is included only as shared context.
Senior Advisor
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Laura Iris Ferro is listed in a Senior Advisor capacity at Claris Ventures. The firm does not publish a person-specific investment thesis for this role; firm strategy is included only as shared context.
Senior Advisor
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Manilo Marocco is listed in a Senior Advisor capacity at Claris Ventures. The firm does not publish a person-specific investment thesis for this role; firm strategy is included only as shared context.
Entrepreneur in Residence
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Michael Hodges invests or supports investment decisions through Claris Ventures's published strategy: Build and invest in biopharma companies arising from the Italian research ecosystem around transformational therapies for major unmet patient needs.
Senior Advisor
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Luca Melindo is listed in a Senior Advisor capacity at Claris Ventures. The firm does not publish a person-specific investment thesis for this role; firm strategy is included only as shared context.
Independent Director
Claris Ventures
Check: Claris Ventures does not publish a standard check-size range on its current official site.
Cristina Tumiatti invests or supports investment decisions through Claris Ventures's published strategy: Build and invest in biopharma companies arising from the Italian research ecosystem around transformational therapies for major unmet patient needs.